FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2791731545> ?p ?o ?g. }

• W2791731545 endingPage "365" @default.
• W2791731545 startingPage "348" @default.
• W2791731545 abstract "Summary We examined the assay formats used to detect anti-drug antibodies (ADA) in clinical studies of the anti-tumour necrosis factor (TNF) monoclonal antibodies adalimumab and infliximab in chronic inflammatory disease and their potential impact on pharmacokinetic and clinical outcomes. Using findings of a recent systematic literature review of the immunogenicity of 11 biological/biosimilar agents, we conducted an ancillary qualitative review of a subset of randomized controlled trials and observational studies of the monoclonal antibodies against anti-TNF factor adalimumab and infliximab. Among studies of adalimumab and infliximab, the immunoassay method used to detect antibodies was reported in 91 of 111 (82%) and 154 of 206 (75%) adalimumab and infliximab studies, respectively. In most adalimumab and infliximab studies, an enzyme-linked immunosorbent assay or radioimmunoassay was used [85 of 91 (93%) and 134 of 154 (87%), respectively]. ADA incidence varied widely among assays and inflammatory diseases (adalimumab, 0–87%; infliximab, 0–79%). Pharmacokinetic and clinical outcomes were only reported for ADA-positive patients in 38 of 91 (42%) and 61 of 154 (40%) adalimumab and infliximab studies, respectively. Regardless of assay format or biological used, ADA formation was associated with lower serum concentrations, reduced efficacy and elevated rates of infusion-related reactions. Consistent with previous recommendations to improve interpretation of immunogenicity data for biologicals, greater consistency in reporting of assay methods and clinical consequences of ADA formation may prove useful. Additional standardization in immunogenicity testing and reporting, application of modern, robust assays that satisfy current regulatory expectations and implementation of international standards for marketed products may help to improve our understanding of the impact of immunogenicity to biologics." @default.
• W2791731545 created "2018-03-29" @default.
• W2791731545 creator A5017389503 @default.
• W2791731545 creator A5027031991 @default.
• W2791731545 creator A5031465165 @default.
• W2791731545 creator A5032257419 @default.
• W2791731545 creator A5032554640 @default.
• W2791731545 creator A5041835212 @default.
• W2791731545 creator A5078732483 @default.
• W2791731545 creator A5081850567 @default.
• W2791731545 creator A5082823681 @default.
• W2791731545 creator A5090016333 @default.
• W2791731545 date "2018-03-30" @default.
• W2791731545 modified "2023-10-17" @default.
• W2791731545 title "Immunoassay methods used in clinical studies for the detection of anti-drug antibodies to adalimumab and infliximab" @default.
• W2791731545 cites W1085005885 @default.
• W2791731545 cites W1141204039 @default.
• W2791731545 cites W1176283365 @default.
• W2791731545 cites W1536336065 @default.
• W2791731545 cites W1582570998 @default.
• W2791731545 cites W1588728586 @default.
• W2791731545 cites W1633038464 @default.
• W2791731545 cites W1683001056 @default.
• W2791731545 cites W1759963899 @default.
• W2791731545 cites W1897160555 @default.
• W2791731545 cites W1923174004 @default.
• W2791731545 cites W1924255685 @default.
• W2791731545 cites W1955559925 @default.
• W2791731545 cites W1967295501 @default.
• W2791731545 cites W1969216944 @default.
• W2791731545 cites W1970942128 @default.
• W2791731545 cites W1974735309 @default.
• W2791731545 cites W1975228691 @default.
• W2791731545 cites W1976821928 @default.
• W2791731545 cites W1979364075 @default.
• W2791731545 cites W1980636282 @default.
• W2791731545 cites W1985763670 @default.
• W2791731545 cites W1986704470 @default.
• W2791731545 cites W1987733166 @default.
• W2791731545 cites W1988152800 @default.
• W2791731545 cites W1992626237 @default.
• W2791731545 cites W1992628263 @default.
• W2791731545 cites W1996472975 @default.
• W2791731545 cites W1997999969 @default.
• W2791731545 cites W1998726604 @default.
• W2791731545 cites W2000293965 @default.
• W2791731545 cites W2003560472 @default.
• W2791731545 cites W2003904406 @default.
• W2791731545 cites W2003949246 @default.
• W2791731545 cites W2004824794 @default.
• W2791731545 cites W2005176759 @default.
• W2791731545 cites W2007688932 @default.
• W2791731545 cites W2008114701 @default.
• W2791731545 cites W2008365376 @default.
• W2791731545 cites W2009949918 @default.
• W2791731545 cites W2013361256 @default.
• W2791731545 cites W2015188966 @default.
• W2791731545 cites W2017883234 @default.
• W2791731545 cites W2019714802 @default.
• W2791731545 cites W2022413885 @default.
• W2791731545 cites W2024148297 @default.
• W2791731545 cites W2024363295 @default.
• W2791731545 cites W2025032284 @default.
• W2791731545 cites W2026116536 @default.
• W2791731545 cites W2027142766 @default.
• W2791731545 cites W2030727272 @default.
• W2791731545 cites W2031785853 @default.
• W2791731545 cites W2032008287 @default.
• W2791731545 cites W2033978760 @default.
• W2791731545 cites W2034939253 @default.
• W2791731545 cites W2035913022 @default.
• W2791731545 cites W2037006676 @default.
• W2791731545 cites W2038017077 @default.
• W2791731545 cites W2040157712 @default.
• W2791731545 cites W2041791353 @default.
• W2791731545 cites W2043475933 @default.
• W2791731545 cites W2043780895 @default.
• W2791731545 cites W2046414057 @default.
• W2791731545 cites W2046811689 @default.
• W2791731545 cites W2052322701 @default.
• W2791731545 cites W2060351951 @default.
• W2791731545 cites W2061085657 @default.
• W2791731545 cites W2062766962 @default.
• W2791731545 cites W2062772471 @default.
• W2791731545 cites W2063030494 @default.
• W2791731545 cites W2064565912 @default.
• W2791731545 cites W2066953275 @default.
• W2791731545 cites W2071538770 @default.
• W2791731545 cites W2072218193 @default.
• W2791731545 cites W2072806283 @default.
• W2791731545 cites W2076620119 @default.
• W2791731545 cites W2076973401 @default.
• W2791731545 cites W2081071002 @default.
• W2791731545 cites W2081388746 @default.
• W2791731545 cites W2081987637 @default.
• W2791731545 cites W2082249841 @default.
• W2791731545 cites W2086314427 @default.
• W2791731545 cites W2086415546 @default.

• next